Table 1.
Variables | HPV-16negative | HPV-16positive | p-value |
---|---|---|---|
Gender | |||
Male | 30 (76.9) | 18 (90.0) | 0.222 |
Female | 9 (23.1) | 2 (10.0) | |
Age | |||
<50yr | 10 (25.6) | 7 (35.0) | 0.621 |
50–64yr | 22 (56.4) | 11 (55.0) | |
≥65yr | 7 (18.0) | 2 (10.0) | |
Race | |||
Caucasian | 27 (69.2) | 20 (100.0) | 0.021 |
African American | 10 (25.7) | 0 (0.0) | |
Other | 2 (5.1) | 0 (0.0) | |
Smoking status | |||
Never | 12 (30.8) | 7 (35.0) | 0.257 |
Former | 6 (15.4) | 7 (35.0) | |
Current | 17 (43.6) | 5 (25.0) | |
Unknown | 4 (10.2) | 1 (5.0) | |
Drinking status | |||
Never | 8 (20.5) | 2 (10.0) | 0.585 |
Former | 4 (10.3) | 1 (5.0) | |
Current | 19 (48.7) | 13 (65.0) | |
Unknown | 8 (20.5) | 4 (20.0) | |
Stage | |||
Early (I–II) | 17 (44.7) | 1 (5.26) | 0.003 |
Advanced (III–IV) | 21 (55.3) | 18 (94.74) | |
TNM | |||
Tumor | |||
1 | 16 (42.1) | 7 (36.84) | 0.574 |
2 | 11 (28.9) | 7 (36.84) | |
3 | 8 (21.1) | 5 (26.32) | |
4 | 3 (7.9) | 0 (0.0) | |
Lymph Node | |||
N− | 22 (56.4) | 2 (10.0) | 0.001 |
N+ | 17 (43.6) | 18 (90.0) | |
Tumor Site | |||
Oropharynx | 4 (10.2) | 19 (95.0) | <0.001 |
Oral cavity | 23 (59.0) | 0 | |
Larynx | 9 (23.1) | 0 | |
Hypopharynx | 2 (5.1) | 0 | |
Unknown primary | 1 (2.6) | 1 (5.0) |